These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 19110984)

  • 21. Financial and non-financial conflicts of interests in psychiatry.
    Maj M
    Eur Arch Psychiatry Clin Neurosci; 2010 Nov; 260 Suppl 2():S147-51. PubMed ID: 20936299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The ICMJE Recommendations and pharmaceutical marketing--strengths, weaknesses and the unsolved problem of attribution in publication ethics.
    Matheson A
    BMC Med Ethics; 2016 Apr; 17():20. PubMed ID: 27044283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Reaction to 'Bitter and gilded pills: psychiatry in the light (or shadow) of the pharmaceutical industry' and to 'The importance of public-private cooperation. Comment on Vandereycken'].
    Buis WM
    Tijdschr Psychiatr; 2006; 48(6):500-1; author reply 501-3. PubMed ID: 16956013
    [No Abstract]   [Full Text] [Related]  

  • 24. Financial ties between DSM-IV panel members and the pharmaceutical industry.
    Cosgrove L; Krimsky S; Vijayaraghavan M; Schneider L
    Psychother Psychosom; 2006; 75(3):154-60. PubMed ID: 16636630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extent and impact of industry sponsorship conflicts of interest in dermatology research.
    Perlis CS; Harwood M; Perlis RH
    J Am Acad Dermatol; 2005 Jun; 52(6):967-71. PubMed ID: 15928613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How to manage conflicts of interest with industry?
    Schowalter JE
    Int Rev Psychiatry; 2008 Apr; 20(2):127-33. PubMed ID: 18386202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conflict of interest, disclosure, and trial reports.
    Psaty BM
    JAMA; 2009 Apr; 301(14):1477-9. PubMed ID: 19351946
    [No Abstract]   [Full Text] [Related]  

  • 28. Analysis of conflicts of interest among authors and researchers of European clinical guidelines in cardiovascular medicine.
    Hinton J; Reeves T; Shah BN
    Clin Med (Lond); 2021 Mar; 21(2):e166-e170. PubMed ID: 33762382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can a good tree bring forth evil fruit? The funding of medical research by industry.
    Capps B
    Br Med Bull; 2016 Jun; 118(1):5-15. PubMed ID: 27151955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating solutions to sponsorship bias.
    Doucet M; Sismondo S
    J Med Ethics; 2008 Aug; 34(8):627-30. PubMed ID: 18667655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Note from the editor.
    Freedman R
    Am J Psychiatry; 2010 Nov; 167(11):1407. PubMed ID: 21041255
    [No Abstract]   [Full Text] [Related]  

  • 32. Does source of funding and conflict of interest influence the outcome and quality of spinal research?
    Amiri AR; Kanesalingam K; Cro S; Casey AT
    Spine J; 2014 Feb; 14(2):308-14. PubMed ID: 24231776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An analysis of the clinical development of drugs in Norway for the years 2000 and 2004: the influence of the pharmaceutical industry.
    Winther FO; Hole OP; Nitter-Hauge S
    Eur J Clin Pharmacol; 2007 Oct; 63(10):909-12. PubMed ID: 17673994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Industry-sponsored research.
    Okike K; Kocher MS; Mehlman CT; Bhandari M
    Injury; 2008 Jun; 39(6):666-80. PubMed ID: 18508054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Financial conflicts of interest and their association with outcome and quality of fibromyalgia drug therapy randomized controlled trials.
    Pang WK; Yeter KC; Torralba KD; Spencer HJ; Khan NA
    Int J Rheum Dis; 2015 Jul; 18(6):606-15. PubMed ID: 26012523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conflict of interest in the debate over calcium-channel antagonists.
    Stelfox HT; Chua G; O'Rourke K; Detsky AS
    N Engl J Med; 1998 Jan; 338(2):101-6. PubMed ID: 9420342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Challenges in science and academic-industry interactions.
    Eisman JA; Lorenzo JA
    J Bone Miner Res; 2007 Nov; 22(11):1654-5. PubMed ID: 17931099
    [No Abstract]   [Full Text] [Related]  

  • 38. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conflicts of interest and the quality of recommendations in clinical guidelines.
    Cosgrove L; Bursztajn HJ; Erlich DR; Wheeler EE; Shaughnessy AF
    J Eval Clin Pract; 2013 Aug; 19(4):674-81. PubMed ID: 23731207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug companies and clinical psychology.
    Baker E; Newnes C; Myatt H
    Ethical Hum Sci Serv; 2003; 5(3):247-53. PubMed ID: 15139338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.